Harmony Biosciences Holdings (HRMY) Price & Analysis

Compare

383 Followers

HRMY Stock Chart & Stats

Day’s Range― - ―

52-Week Range$25.95 - $41.61

Previous CloseN/A

Volume87.33K

Average Volume (3M)1.02M

Market Cap

$1.53B

Enterprise Value$1.49B

Total Cash (Recent Filing)$565.27M

Total Debt (Recent Filing)$172.09M

Price to Earnings (P/E)8.5

Beta1.51

Next Earnings

Nov 04, 2025

EPS Estimate

0.74

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.68

Shares Outstanding57,532,600

10 Day Avg. Volume956,412

30 Day Avg. Volume1,022,653

Financial Highlights & Ratios

PEG Ratio0.75

Price to Book (P/B)2.97

Price to Sales (P/S)2.74

P/FCF Ratio8.95

Enterprise Value/Market Cap0.98

Enterprise Value/Revenue1.93

Enterprise Value/Gross Profit2.46

Enterprise Value/Ebitda5.62

Forecast

1Y Price Target

$44.56

Price Target Upside69.04% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering10

Bulls Say, Bears Say

Bulls Say

Commercial PerformanceWAKIX continues to deliver resilient growth, with 16% year-over-year revenue expansion and steady prescriber penetration across both REMS and non-REMS segments.

Financial StrengthHarmony reaffirmed 2025 revenue guidance of $820M–$860M, reinforcing its position as a profitable, self-funding biotech.

Market PenetrationHarmony continues to see healthy demand across both REMS and non-REMS prescribers, with more than 9,000 healthcare providers reached, illustrating successful commercial penetration into previously untapped segments.

Bears Say

Market CompetitionPitolisant lifecycle programs are not well characterized in terms of differentiation in an increasingly competitive narcolepsy market.

Pipeline ChallengesConcerns exist that the epilepsy program lacks differentiation and the orexin program is entering a crowded market.

Pipeline SetbackThe Ph3 RECONNECT study missed its primary endpoint, leading to a major pipeline setback for Harmony Biosciences.

Harmony Biosciences Holdings News

Harmony Biosciences price target lowered to $36 from $54 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Harmony Biosciences (HRMY) to $36 from $54 and keeps a...

20d ago

HRMY

Harmony Biosciences price target lowered to $35 from $50 at Mizuho

Mizuho lowered the firm’s price target on Harmony Biosciences (HRMY) to $35 from $50 and keeps an Outperform...

20d ago

HRMY

Harmony Biosciences price target lowered to $55 from $70 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Harmony Biosciences (HRMY) to $55 from $70 and keeps a...

20d ago

HRMY

Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories

Earnings AI, trade talks, and more are leading the biggest stock market stories on Wednesday. ...

20d ago

Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz

The major averages were lower in early afternoon trading following yesterday’s sharp pullback as investors digest Fed Chair...

20d ago

Harmony growth in question after negative data, says Mizuho

Mizuho believes Harmony Biosciences (HRMY)’ near-term growth is “now a bigger question” after the company announced a negative...

21d ago

HRMY

Morning Movers: uniQure skyrockets after AMT-130 trial meets primary endpoint

Futures are nudging upward, suggesting a modest rebound in sentiment. Markets look set to open on a tentative...

21d ago

LAC

THO

Harmony Biosciences Stock (HRMY) Sinks on Failed Phase 3 Study

Harmony Biosciences stock fell hard on Wednesday after the company posted poor Phase 3 clinical trial results. ...

21d ago

HRMY

Harmony Biosciences announces RECONNECT study did not meet primary endpoint

Harmony Biosciences (HRMY) announced topline results from its Phase 3 registrational clinical trial of ZYN002 in Fragile X...

21d ago

HRMY

Sell Rating for Harmony Biosciences: Setbacks in R&D and Uncertain Pipeline Outlook

In a report released yesterday, Jason Gerberry from Bank of America Securities maintained a Sell rating on Harmony...

20d ago

HRMY

Harmony Biosciences Phase 3 Study Misses Endpoint

Harmony Biosciences Holdings ( ($HRMY) ) has shared an update. On September 24, 2025, Harmony Biosciences announced that...

20d ago

HRMY

Harmony Biosciences Holdings: Strong Buy Rating Backed by Wakix Success and Robust Pipeline

In a report released today, Ami Fadia from Needham reiterated a Buy rating on Harmony Biosciences Holdings, with...

21d ago

HRMY

Harmony Biosciences price target lowered to $48 from $49 at Needham

Needham lowered the firm’s price target on Harmony Biosciences (HRMY) to $48 from $49 and keeps a Buy...

1M ago

TAK

HRMY

Harmony Biosciences: Buy Rating Affirmed on Strong Growth Prospects and Strategic Advancements

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating on Harmony Biosciences Holdings today and set a price...

2M ago

HRMY

HRMY FAQ

What was Harmony Biosciences Holdings’s price range in the past 12 months?

Harmony Biosciences Holdings lowest stock price was $25.95 and its highest was $41.61 in the past 12 months.

What is Harmony Biosciences Holdings’s market cap?

Harmony Biosciences Holdings’s market cap is $1.53B.

When is Harmony Biosciences Holdings’s upcoming earnings report date?

Harmony Biosciences Holdings’s upcoming earnings report date is Nov 04, 2025 which is in 20 days.

How were Harmony Biosciences Holdings’s earnings last quarter?

Harmony Biosciences Holdings released its earnings results on Jul 31, 2025. The company reported $0.68 earnings per share for the quarter, missing the consensus estimate of $0.705 by -$0.025.

Is Harmony Biosciences Holdings overvalued?

According to Wall Street analysts Harmony Biosciences Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Harmony Biosciences Holdings pay dividends?

Harmony Biosciences Holdings does not currently pay dividends.

What is Harmony Biosciences Holdings’s EPS estimate?

Harmony Biosciences Holdings’s EPS estimate is 0.74.

How many shares outstanding does Harmony Biosciences Holdings have?

Harmony Biosciences Holdings has 57,532,600 shares outstanding.

What happened to Harmony Biosciences Holdings’s price movement after its last earnings report?

Harmony Biosciences Holdings reported an EPS of $0.68 in its last earnings report, missing expectations of $0.705. Following the earnings report the stock price went down -0.846%.

Which hedge fund is a major shareholder of Harmony Biosciences Holdings?

Currently, no hedge funds are holding shares in HRMY

Harmony Biosciences Holdings Stock Smart Score

Neutral

Fundamentals

Return on Equity

27.58%

Trailing 12-Months

Asset Growth

29.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Harmony Biosciences Holdings

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.

Harmony Biosciences Holdings (HRMY) Earnings & Revenues

Historic Earnings Reports

HRMY Stock 12 Month Forecast

Average Price Target

$44.56

▲(69.04% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"28":"$28","63":"$63","36.75":"$36.8","45.5":"$45.5","54.25":"$54.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$62.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":44.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$44.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$31.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[28,36.75,45.5,54.25,63],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.1,39.01538461538462,40.93076923076923,42.84615384615385,44.761538461538464,46.676923076923075,48.59230769230769,50.50769230769231,52.42307692307692,54.33846153846154,56.253846153846155,58.169230769230765,60.08461538461538,{"y":62,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.1,37.673846153846156,38.24769230769231,38.821538461538466,39.395384615384614,39.96923076923077,40.543076923076924,41.11692307692308,41.690769230769234,42.26461538461539,42.838461538461544,43.41230769230769,43.98615384615385,{"y":44.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,37.1,36.63076923076923,36.16153846153846,35.69230769230769,35.223076923076924,34.753846153846155,34.284615384615385,33.815384615384616,33.34615384615385,32.87692307692308,32.40769230769231,31.93846153846154,31.46923076923077,{"y":31,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":35.98,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.24,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.08,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.13,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.41,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.85,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.42,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.86,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.56,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.03,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >